Transcription of GUIDELINES ON VALIDATION APPENDIX 4 …
{{id}} {{{paragraph}}}
Working document June 2016 Draft document for comment 1 GUIDELINES ON VALIDATION APPENDIX 4 2 ANALYTICAL METHOD VALIDATION 3 (June 2016) 4 DRAFT FOR COMMENTS 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 World Health Organization 2016 25 All rights reserved. 26 This draft is intended for a restricted audience only, the individuals and organizations having received this draft. The draft 27 may not be reviewed, abstracted, quoted, reproduced, transmitted, distributed, translated or adapted, in part or in whole, in any 28 form or by any means outside these individuals and organizations (including the organizations' concerned staff and member 29 organizations) without the permission of the World Health Organization.
Working document QAS/16.671 page 3 90 Background information 91 92 The need for revision of the published Supplementary guidelines on good manufacturing practices: validation 93 (1) was identified by the Prequalification of Medicines Programme and a 94 draft document was circulated for comment in early 2013. The focus of the revision was the 95 Appendix on non-sterile process validation ...
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
14227/DT190412P36 Development, Validation, Method, Quality, Method Validation for Quantitative, Method Validation for Quantitative Analysis in, VALIDATION OF ANALYTICAL METHODS FOR, Validation of Analytical Methods for Food Control, Method Validation, CHROMATOGRAPHIC METHOD FOR THE ESTIMATION, Quality Management systems - Process Validation, Quality Management Systems Process Validation Guidance, Control, Chapter-2 Analytical Method Development and, Chapter-2 Analytical Method Development and Validation, Validation of a Dissolution, Validation of a Dissolution Method for Clomipramine